These resources include the Janssen Business Development group and, under the umbrella of Johnson & Johnson Innovation, the company’s incubators JLABS and JPODS, innovation centers located in ...

Pharma Mar SA (ES:PHM) has released an update. Pharma Mar S.A. has received a significant payment of $10 million from Janssen ...

Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...

Spanish drugmaker PharmaMar Group today said it has received a payment of $10 million from Janssen Products, a Johnson & ...

Transferred US sponsorship of global Phase 3 NANORAY-312 head and neck cancer study, a key step in the preparation for potential NBTXR3 ...

In a dramatic turn of events that makes for some great storytelling, Cidara's novel drug-Fc conjugate, once locked up in a ...

Third Quarter 2024 Operational Highlights In an important step forward for the potential NBTXR3 regulatory pathway, Nanobiotix and Janssen Pharmaceutica NV, a Johnson & Johnson Company ("Janssen"), ...

Daniel Baker, M.D., will join Cue Biopharma’s executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish ...

A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Want to share your experience with this dealership? Worked well with me on the car and price. No ...

Not rated Dealerships need five reviews in the past 24 months before we can display a rating. (5 reviews) 7 Great Deals out of 33 listings starting at $6,200 7 Great Deals out of 33 listings ...

G&A Expenditures: For the three months ended September 30, 2024, G&A increased by CHF 0.3 million to CHF 3.8 million, mostly due to an increase in salaries and related costs, primarily due to new ...

Lawyers for AstraZeneca , Bristol Myers Squibb and Johnson & Johnson's Janssen on Wednesday urged a federal appeals court in ...